CA 19-9 抗体
-
- 抗原 See all CA 19-9 抗体
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CA 19-9 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 特异性
- The antibody 121SLE recognizes Sialyl Lewis a-containing glycolipids (extracellular plasma membrane leaflet antigens).
- 交叉反应 (详细)
- Other not tested, Human
- 纯化方法
- Purified by sequential steps of physicochemical fractionation (differential precipitation and solid-phase chromatography methods).
- 纯度
- > 95 % (by SDS-PAGE)
- 免疫原
- Immunoprecipitate obtained after immunodiffusion of MAb 19-9 and mucins isolated from an ovarian cyst of a 0Le(a+b-) patient.
- 克隆位点
- 121SLE
- 亚型
- IgM
-
-
- 应用备注
- Immunohistochemistry (paraffin sections): Recommended dilution: 10 μg/mL, positive control: colorectal adenocarcinoma, heat mediated antigen retrieval (sodium citrate), mAb incubation 1 hour / RT, detection DAB.
- 限制
- 仅限研究用
-
- 浓度
- 1 mg/mL
- 缓冲液
- Tris buffered saline (TBS), pH 8.0, 15 mM sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Do not freeze.
- 储存条件
- 4 °C
- 储存方法
- Store at 2-8°C. Do not freeze.
-
-
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." in: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).
: "
-
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." in: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).
-
- 抗原
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
- 别名
- Sialyl Lewis a (CA 19-9 产品)
- 背景
- CA-19.9
-